0001104659-17-038154.txt : 20170608 0001104659-17-038154.hdr.sgml : 20170608 20170608161515 ACCESSION NUMBER: 0001104659-17-038154 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170606 FILED AS OF DATE: 20170608 DATE AS OF CHANGE: 20170608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gibbs Michael Terrence CENTRAL INDEX KEY: 0001665000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 17900382 MAIL ADDRESS: STREET 1: 12 STONEY BROOK RD. CITY: HOPKINTON STATE: MA ZIP: 01748 4 1 a4.xml 4 X0306 4 2017-06-06 0 0001492674 T2 Biosystems, Inc. TTOO 0001665000 Gibbs Michael Terrence 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 General Counsel Common Stock 2017-06-06 4 P 0 1000 3.51 A 10431 D The price reported is a weighted average price. The shares were purchased in multiple transactions at per share price ranging from $3.50 to $3.52. The reporting person undertakes to provide upon request the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes 9,331 shares acquired shares acquired under the Issuer's employee stock purchase plan between November 15, 2015 and May 15, 2017. /s/ Darlene Deptula-Hicks, Attorney-in-fact 2017-06-08